Terms ending in 2034
Every in-force patent on Glytec, LLC's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,604,002 | Insulin Management In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 9,710,611 | Insulin Management In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 9,892,235 | Insulin Management In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 11,490,837 | Insulin Management In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 11,857,314 | Insulin Management In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 12,127,831 | Insulin Management In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 9,233,204 | Insulin Management In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 9,504,789 | Insulin Management In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 10,255,992 | Insulin Management In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 10,535,426 | Insulin Management In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| 8 more term ends in 2034 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.